Reference
Vanderpoel J, et al. Health Care Resource Utilization and Costs Associated With Switching Biologics in Rheumatoid Arthritis. Clinical Therapeutics : 20 May 2019. Available from: URL: http://doi.org/10.1016/j.clinthera.2019.04.032
Rights and permissions
About this article
Cite this article
Switching biologicals increases costs in patients with RA. PharmacoEcon Outcomes News 830, 33 (2019). https://doi.org/10.1007/s40274-019-5984-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5984-5